mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils

Detalles Bibliográficos
Autores principales: Rubin-Bejerano, Ifat, Sansal-Castellano, Isabelle, Carlson, Mark, Reznik, Gabriel, Siedlecki, James, Kane, John, Dostalova, Zuzana, Miao, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292566/
http://dx.doi.org/10.1186/2051-1426-2-S3-P262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292566/
http://dx.doi.org/10.1186/2051-1426-2-S3-P262

Ejemplares similares